266 related articles for article (PubMed ID: 10586939)
1. Evidence for TIMP-1 protection against P. aeruginosa-induced corneal ulceration and perforation.
Kernacki KA; Barrett R; Hazlett LD
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3168-76. PubMed ID: 10586939
[TBL] [Abstract][Full Text] [Related]
2. TIMP-1 role in protection against Pseudomonas aeruginosa-induced corneal destruction.
Kernacki KA; Chunta JL; Barrett RP; Hazlett LD
Exp Eye Res; 2004 Jun; 78(6):1155-62. PubMed ID: 15109922
[TBL] [Abstract][Full Text] [Related]
3. Aging and PMN response to P. aeruginosa infection.
Kernacki KA; Barrett RP; McClellan SA; Hazlett LD
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3019-25. PubMed ID: 10967059
[TBL] [Abstract][Full Text] [Related]
4. Spantide I decreases type I cytokines, enhances IL-10, and reduces corneal perforation in susceptible mice after Pseudomonas aeruginosa infection.
Hazlett LD; McClellan SA; Barrett RP; Liu J; Zhang Y; Lighvani S
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):797-807. PubMed ID: 17251480
[TBL] [Abstract][Full Text] [Related]
5. Role of IL-12 and IFN-gamma in Pseudomonas aeruginosa corneal infection.
Hazlett LD; Rudner XL; McClellan SA; Barrett RP; Lighvani S
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):419-24. PubMed ID: 11818386
[TBL] [Abstract][Full Text] [Related]
6. Early TIMP gene expression after corneal infection with Pseudomonas aeruginosa.
Kernacki KA; Goebel DJ; Poosch MS; Hazlett LD
Invest Ophthalmol Vis Sci; 1998 Feb; 39(2):331-5. PubMed ID: 9477990
[TBL] [Abstract][Full Text] [Related]
7. Further studies on the role of IL-12 in Pseudomonas aeruginosa corneal infection.
Hazlett LD; Huang X; McClellan SA; Barrett RP
Eye (Lond); 2003 Nov; 17(8):863-71. PubMed ID: 14631390
[TBL] [Abstract][Full Text] [Related]
8. Aged mice fail to upregulate ICAM-1 after Pseudomonas aeruginosa corneal infection.
Hobden JA; Masinick SA; Barrett RP; Hazlett LD
Invest Ophthalmol Vis Sci; 1995 May; 36(6):1107-14. PubMed ID: 7730020
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Pseudomonas aeruginosa corneal infection in IL-1 beta converting enzyme (ICE, caspase-1) deficient mice.
Thakur A; Barrett RP; McClellan S; Hazlett LD
Curr Eye Res; 2004; 29(4-5):225-33. PubMed ID: 15590467
[TBL] [Abstract][Full Text] [Related]
11. Substance P promotes susceptibility to Pseudomonas aeruginosa keratitis in resistant mice: anti-inflammatory mediators downregulated.
McClellan SA; Zhang Y; Barrett RP; Hazlett LD
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1502-11. PubMed ID: 18385069
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase-9 amplifies the immune response to Pseudomonas aeruginosa corneal infection.
McClellan SA; Huang X; Barrett RP; Lighvani S; Zhang Y; Richiert D; Hazlett LD
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):256-64. PubMed ID: 16384971
[TBL] [Abstract][Full Text] [Related]
13. Lecithin-bound superoxide dismutase in the prevention of neutrophil-induced damage of corneal tissue.
Matsumoto K; Shimmura S; Goto E; Saito K; Takeuchi T; Miyajima S; Negi A; Tsubota K
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):30-5. PubMed ID: 9430542
[TBL] [Abstract][Full Text] [Related]
14. Effect of vitamin A deficiency on the early response to experimental Pseudomonas keratitis.
Twining SS; Zhou X; Schulte DP; Wilson PM; Fish B; Moulder J
Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):511-22. PubMed ID: 8595951
[TBL] [Abstract][Full Text] [Related]
15. TLR4 is required for host resistance in Pseudomonas aeruginosa keratitis.
Huang X; Du W; McClellan SA; Barrett RP; Hazlett LD
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4910-6. PubMed ID: 17065506
[TBL] [Abstract][Full Text] [Related]
16. MIP-1alpha regulates CD4+ T cell chemotaxis and indirectly enhances PMN persistence in Pseudomonas aeruginosa corneal infection.
Kernacki KA; Barrett RP; McClellan S; Hazlett LD
J Leukoc Biol; 2001 Dec; 70(6):911-9. PubMed ID: 11739554
[TBL] [Abstract][Full Text] [Related]
17. Increased severity of Pseudomonas aeruginosa corneal infection in strains of mice designated as Th1 versus Th2 responsive.
Hazlett LD; McClellan S; Kwon B; Barrett R
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):805-10. PubMed ID: 10711697
[TBL] [Abstract][Full Text] [Related]
18. Induction of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs correlates with outcome of acute experimental pseudomonal keratitis.
Ikema K; Matsumoto K; Inomata Y; Komohara Y; Miyajima S; Takeya M; Tanihara H
Exp Eye Res; 2006 Dec; 83(6):1396-404. PubMed ID: 16968651
[TBL] [Abstract][Full Text] [Related]
19. Silencing Toll-like receptor-9 in Pseudomonas aeruginosa keratitis.
Huang X; Barrett RP; McClellan SA; Hazlett LD
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4209-16. PubMed ID: 16249500
[TBL] [Abstract][Full Text] [Related]
20. Transplantation of amniotic membrane in murine herpes stromal keratitis modulates matrix metalloproteinases in the cornea.
Heiligenhaus A; Li HF; Yang Y; Wasmuth S; Steuhl KP; Bauer D
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4079-85. PubMed ID: 16249483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
